» Articles » PMID: 31158496

Biodegradable Atrial Septal Defect Occluders: A Current Review

Overview
Journal Acta Biomater
Publisher Elsevier
Date 2019 Jun 4
PMID 31158496
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Atrial septal defect (ASD) is a common structural congenital heart disease. With the development of interventional closure devices and transcatheter techniques, interventional closure therapy has become the most well-accepted therapeutic alternative worldwide, as it offers a number of advantages over conventional therapies such as improved safety, easier operation, lower complication rates and invasiveness, and shorter anesthetic time and hospitalizations. During the past decades, various types of occluders based on nondegradable shape memory alloys have been used in clinical applications. Considering that the permanent existence of foreign nondegradable materials in vivo can cause many potential complications in the long term, the research and development of biodegradable occluders has emerged as a crucial issue for interventional treatment of ASD. This review aims to summarize partially or fully biodegradable occlusion devices currently reported in the literature from the aspects of design, construction, and evaluation of animal experiments. Furthermore, a comparison is made on the advantages and disadvantages of the materials used in biodegradable ASD occlusion devices, followed by an analysis of the problems and limitations of the occlusion devices. Finally, several strategies are proposed for future development of biodegradable cardiac septal defect occlusion devices. STATEMENT OF SIGNIFICANCE: Although occlusion devices based on nondegradable alloys have been widely used in clinical applications and saved numerouspatients, biodegradable occlusion devices may offer some advantages such as fewer complications, acceptable biocompatibility, and particularly temporary existence, thereby leaving "native" tissue behind, which will certainly become the development trend in the long term. This review summarizes almost all partially or fully biodegradable occlusion devices currently reported in the literature from the aspects of design, construction, and evaluation of animal experiments. Furthermore, a comparison is made on the advantages and disadvantages of the materials used in biodegradable ASD occlusion devices, followed by an analysis of the problems and limitations of the occlusion devices. Finally, several strategies are proposed for future development of biodegradable cardiac septal defect occlusion devices.

Citing Articles

Recent Development of Biodegradable Occlusion Devices for Intra-Atrial Shunts.

Li Y, Chen Z, Xie Z, Wang S, Xie Y, Zhang Z Rev Cardiovasc Med. 2024; 25(5):159.

PMID: 39076475 PMC: 11267192. DOI: 10.31083/j.rcm2505159.


The 3-year follow-up of a fully biodegradable implantable device closure for perimembranous ventricular septal defects in children using echocardiography.

Cong J, Cui C, Huang D, Wang Y, Liu S, Song S Front Cardiovasc Med. 2024; 11:1420704.

PMID: 39015679 PMC: 11250614. DOI: 10.3389/fcvm.2024.1420704.


Assessment of degradability and endothelialization of modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluders over time in vivo.

Chen J, Xie Y, Li Y, Chen X, Fu M, Liu Y J Cardiothorac Surg. 2023; 18(1):283.

PMID: 37817186 PMC: 10566106. DOI: 10.1186/s13019-023-02401-3.


Favorable mid-term performance of fully biodegradable implantable device for ventricular septal defect closure.

Song S, Shao Z, Fan T, Li B, Liang W, Dong H JTCVS Tech. 2023; 17:133-137.

PMID: 36820343 PMC: 9938384. DOI: 10.1016/j.xjtc.2022.11.010.


Key Regulatory Differentially Expressed Genes in the Blood of Atrial Septal Defect Children Treated With Occlusion Devices.

Li B, Tang Q, Tan Y, Yan L, Sun L, Guo W Front Genet. 2021; 12:790426.

PMID: 34956331 PMC: 8692776. DOI: 10.3389/fgene.2021.790426.